Evidence map›Paper›PMID 40475120›Full record

SynthesisFrontiers in global women's health2025

Through a gender lens: a scoping review of gendered experiences of AMR causes, burden and workforce in Nigeria.

Ayodele Oluwakemi Majekodunmi, Mabel Kamweli Aworh, Esteller Mbadiwe, Kikiope Oluwafikemi Oluwarore, Mwapu Dika Ndahi, Dooshima Kwange

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in global women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ayodele Oluwakemi MajekodunmiFood and Agriculture Organisation of the United Nations, Abuja, Nigeria.
Mabel Kamweli AworhDepartment of Biological and Forensic Sciences, Fayetteville State University, Fayetteville, NC, United States.
Esteller MbadiweDucit Blue Solutions, Abuja, Nigeria.
Kikiope Oluwafikemi OluwaroreOne Health Development Initiative, Abuja, Nigeria.
Mwapu Dika NdahiDepartment of Veterinary and Pest Control Services, Federal Ministry of Agriculture and Food Security, Abuja, Nigeria.
Dooshima KwangeTesedona Foundation for Animal Health, Abuja, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Nigeria is among the countries with the top 10 highest burdens of infectious and zoonotic diseases worldwide. There is a correspondingly high rate of antimicrobial use and misuse in humans and animals, leading to antimicrobial resistance (AMR). Antimicrobial Resistance has a very high impact on women and girls as they form the majority of health workers at community level as well as being the main care givers and livestock custodians in the home, most likely to prescribe, purchase or administer antibiotics. However, there is very little information about gendered aspects of AMR in Nigeria. This paper undertakes a scoping review of antimicrobial resistance in Nigeria through a gender lens, looking at how sex and gender interact with antimicrobial resistance and efforts to mitigate its negative effects. Methods: A PRISMA scoping review was conducted for peer-reviewed articles published from the year 2000, describing studies in Nigeria on AMR, infectious disease treatment (including treatment seeking behaviour) and access and experiences of healthcare, which either take an explicit gender approach or include sex/gender as a key variable. Results: Studies show clear gender differences in levels of disease risk/resistance, health-seeking behaviour and patterns of access to healthcare (including antimicrobials). Despite the fact that these patterns are clearly recognised across multiple publications in different settings, we did not find evidence of a corresponding analysis of how gender might reinforce these vulnerabilities. Conclusions: Gendered aspects of infectious diseases, antimicrobial access and resistance are documented in Nigeria, albeit often incidentally. This data should be taken into account when considering the AMR problem and in the design of various interventions and the design of various interventions towards improving AMR and One Health in Nigeria.

Indexed as

antimicrobial resistance (AMR)genderinequityinfectious diseasesNigeria

Identifiers

PMID40475120
PMCPMC12137349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.